<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6541733\results\search\disease\results.xml">
  <result pre="are an important cause of morbidity and mortality associated with" exact="influenza" post="infections. As bacterial disease can be caused by a"/>
  <result pre="cause of morbidity and mortality associated with influenza infections. As" exact="bacterial disease" post="can be caused by a disturbance of the host"/>
  <result pre="disturbance of the host microbiome, we examined the impact of" exact="influenza" post="on the upper respiratory tract microbiome in a human"/>
  <result pre="ecology of the throat microbiome were examined following an experimental" exact="influenza" post="challenge of 52 previously-healthy adult volunteers with influenza A/Wisconsin/67/2005"/>
  <result pre="an experimental influenza challenge of 52 previously-healthy adult volunteers with" exact="influenza" post="A/Wisconsin/67/2005 (H3N2) by intranasal inoculation; 35 healthy control subjects"/>
  <result pre="detected. Results Of the 52 challenged individuals, 43 developed proven" exact="influenza" post="infections, 33 of whom became symptomatic. None of the"/>
  <result pre="influenza, with no significant differences over time between individuals with" exact="influenza" post="and those in the control group. Influenza infection was"/>
  <result pre="or Neisseria meningitidis. Conclusions The throat microbiota is resilient to" exact="influenza" post="infection, indicating the robustness of the upper-airway microbiome. Secondary"/>
  <result pre="the upper-airway microbiome. Secondary bacterial infections cause significant morbidity following" exact="influenza" post="virus infection. We show that influenza A virus infection"/>
  <result pre="cause significant morbidity following influenza virus infection. We show that" exact="influenza" post="A virus infection does not have a major impact"/>
  <result pre="indicating that microbial communities are robust in this site. microbiome" exact="influenza" post="upper respiratory tract Funding Centers for Disease Control and"/>
  <result pre="major cause of the mortality and morbidity associated with the" exact="influenza" post="virus [1]. Bacterial pneumonia caused millions of deaths during"/>
  <result pre="mortality and morbidity associated with the influenza virus [1]. Bacterial" exact="pneumonia" post="caused millions of deaths during influenza epidemics in the"/>
  <result pre="influenza virus [1]. Bacterial pneumonia caused millions of deaths during" exact="influenza" post="epidemics in the 20th century [2]. For example, 94%"/>
  <result pre="of a group of patients who died in the 1918" exact="influenza" post="pandemic had evidence of secondary bacterial pneumonia [3], while"/>
  <result pre="died in the 1918 influenza pandemic had evidence of secondary" exact="bacterial pneumonia" post="[3], while 28% of fatalities in New York associated"/>
  <result pre="in the 1918 influenza pandemic had evidence of secondary bacterial" exact="pneumonia" post="[3], while 28% of fatalities in New York associated"/>
  <result pre="of fatalities in New York associated with the 2009 H1N1" exact="influenza" post="pandemic had bacterial co-infections, with most diagnosed post-mortem [4]."/>
  <result pre="common that it was initially thought to be the cause" exact="influenza" post="[5]. Streptococcus pneumoniae is the commonest influenza-associated infection [6],"/>
  <result pre="is the commonest influenza-associated infection [6], while cavitatory Staphylococcus aureus" exact="pneumonia" post="is a severe influenza complication; secondary pneumonia with methicillin"/>
  <result pre="infection [6], while cavitatory Staphylococcus aureus pneumonia is a severe" exact="influenza" post="complication; secondary pneumonia with methicillin resistant Staphylococcus aureus emerged"/>
  <result pre="cavitatory Staphylococcus aureus pneumonia is a severe influenza complication; secondary" exact="pneumonia" post="with methicillin resistant Staphylococcus aureus emerged in the 2009"/>
  <result pre="the 2009 pandemic [7]. There is also an association between" exact="influenza" post="A and Neisseria meningitidis disease [8]. Multiple mechanisms could"/>
  <result pre="meningitidis disease [8]. Multiple mechanisms could explain the development of" exact="bacterial disease" post="following influenza. The virus is cytolytic and induces epithelial"/>
  <result pre="a more diverse nasopharyngeal microbiome compared with patients suffering from" exact="pneumonia" post="[22], while a highly diverse community is found in"/>
  <result pre="a highly diverse community is found in patients with asthma," exact="cystic fibrosis," post="or Chronic Obstructive Pulmonary Disease [23, 24]. However, little"/>
  <result pre="understand secondary bacterial infections, we investigated the impact of the" exact="influenza" post="virus on the human nasopharyngeal microbiome. Using 454 pyrosequencing,"/>
  <result pre="over a 30-day period in 52 healthy adults challenged with" exact="influenza" post="A H3N2 and in 32 non-challenged individuals. This approach"/>
  <result pre="us to define changes in the human microbiome following an" exact="influenza" post="challenge. Furthermore, we examined whether influenza affected the carriage"/>
  <result pre="human microbiome following an influenza challenge. Furthermore, we examined whether" exact="influenza" post="affected the carriage of pathogens in the upper airways."/>
  <result pre="and 45; were not living with anyone at risk of" exact="influenza" post="complications; and had not had an influenza vaccine in"/>
  <result pre="at risk of influenza complications; and had not had an" exact="influenza" post="vaccine in the last 3 years. Blood samples from"/>
  <result pre="challenge group were inoculated intranasally with 5.5 log10 TCID50/ml/nostril of" exact="influenza" post="strain A/H3N2/Wisconsin/67/2005. The control group members were not subjected"/>
  <result pre="unit on the day before receiving an intranasal challenge of" exact="influenza" post="A (on day 0), then were followed for 28"/>
  <result pre="were analysed by hemagglutination inhibition (HAI) and microneutralization assays. Laboratory-confirmed" exact="influenza" post="was defined as either a 4-fold or greater rise"/>
  <result pre="viral challenge and had an ILI, with evidence of an" exact="influenza" post="infection (n = 19); the Sflu+ group consisted of"/>
  <result pre="the viral challenge and were symptomatic, with evidence of an" exact="influenza" post="infection (n = 14); and the ILI/Sflu+ group consisted"/>
  <result pre="groups (n = 33). Those who were not challenged with" exact="influenza" post="and remained asymptomatic/influenza-negative formed the AC (asymptomatic control) group"/>
  <result pre="After Influenza Challenge Although volunteers were screened for antibodies against" exact="influenza" post="in advance, 3 individuals in the challenge group and"/>
  <result pre="in 43 of the 52 individuals (82%) subjected to the" exact="influenza" post="challenge; 33 subjects developed symptoms, including 19 with ILI"/>
  <result pre="with ILI (ILIflu+). An additional 3 subjects were challenged with" exact="influenza" post="and became symptomatic, but had no evidence of influenza"/>
  <result pre="with influenza and became symptomatic, but had no evidence of" exact="influenza" post="infection. There were 3 other challenged individuals that remained"/>
  <result pre="(white boxes) and asymptomatic control (grey boxes) groups following the" exact="influenza" post="A challenge. The box whisker plots extend from the"/>
  <result pre="structure in the ILI/Sflu+ and asymptomatic control groups during the" exact="influenza" post="challenge. The PCoA was based on the Thetayc index,"/>
  <result pre="The abundance of each phylum remained remarkably constant following the" exact="influenza" post="challenge. There was a significant change in the Bacteroidetes"/>
  <result pre="(P = .8163). Figure 9. Neisseria meningitidis carriage following the" exact="influenza" post="challenge. Meningococcal carriage in (A) the ILI/Sflu+ group and"/>
  <result pre="challenge. The carriage of non-groupable N. meningitidis was unchanged during" exact="influenza" post="infection and ranged between 11.4 and 13.5%, except for"/>
  <result pre="prospective characterization of bacterial communities within the human URT during" exact="influenza" post="infection. Previous studies have examined changes in the microbiota"/>
  <result pre="Furthermore, cross-sectional studies have characterized the microbiomes of patients with" exact="influenza" post="[42]. However we are not aware of a previous"/>
  <result pre="of a previous study that examined individuals during a defined" exact="influenza" post="challenge. We detected slight perturbations in the upper respiratory"/>
  <result pre="perturbations in the upper respiratory microbiota following a challenge with" exact="influenza" post="A. There was a high level of inter-individual variation"/>
  <result pre="with this increase, little is known about its role in" exact="respiratory disease." post="Overall, our study does not provide evidence that influenza"/>
  <result pre="respiratory disease. Overall, our study does not provide evidence that" exact="influenza" post="infection has a marked impact in shaping the pharyngeal"/>
  <result pre="Neisseria. Even though cohort studies have established a relationship between" exact="influenza" post="and the rate of pneumococcal carriage, we did not"/>
  <result pre="we did not find differences in pneumococcal carriage following an" exact="influenza" post="infection. For the meningococcus, we also examined capsule expression,"/>
  <result pre="encapsulated or non-encapsulated N. meningitidis with the advent of an" exact="influenza" post="infection. We did not examine swabs for the presence"/>
  <result pre="presence of S. aureus, as this secondary bacteria pathogen follows" exact="influenza" post="far less frequently than S. pneumoniae and is associated"/>
  <result pre="demonstrate that the upper airway microbiota is not reprogrammed by" exact="influenza" post="infection, with only minor perturbations in bacterial communities, similar"/>
  <result pre="have been disclosed. References References 1.SmithAM, McCullersJASecondary bacterial infections in" exact="influenza" post="virus infection pathogenesis. Curr Top Microbiol Immunol2014; 385:327â€&quot;56.25027822 2.MorensDM,"/>
  <result pre="infection pathogenesis. Curr Top Microbiol Immunol2014; 385:327â€&quot;56.25027822 2.MorensDM, FauciASThe 1918" exact="influenza" post="pandemic: insights for the 21st century. J Infect Dis2007;"/>
  <result pre="series of 68 cases dying before and during the 1918" exact="influenza" post="pandemic peak. Proc Natl Acad Sci USA2011; 108:16416â€&quot;21.21930918 4.LeeEH,"/>
  <result pre="4.LeeEH, WuC, LeeEU, et al.Fatalities associated with the 2009 H1N1" exact="influenza" post="A virus in New York city. Clin Infect Dis2010;"/>
  <result pre="Clin Infect Dis2010; 50:1498â€&quot;504.20420514 5.SmithW, AndrewesCH, LaidlawPPA virus obtained from" exact="influenza" post="patients. Lancet1933; 2:66â€&quot;8. 6.McCullersJAInsights into the interaction between influenza"/>
  <result pre="from influenza patients. Lancet1933; 2:66â€&quot;8. 6.McCullersJAInsights into the interaction between" exact="influenza" post="virus and pneumococcus. Clin Microbiol Rev2006; 19:571â€&quot;82.16847087 7.MurrayRJ, RobinsonJO,"/>
  <result pre="pneumococcus. Clin Microbiol Rev2006; 19:571â€&quot;82.16847087 7.MurrayRJ, RobinsonJO, WhiteJN, et al.Community-acquired" exact="pneumonia" post="due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus"/>
  <result pre="respiratory tract. Pediatr Infect Dis J2009; 28:S121â€&quot;6.19918134 11.McCullersJAThe co-pathogenesis of" exact="influenza" post="viruses with bacteria in the lung. Nat Rev Microbiol2014;"/>
  <result pre="Microbiol2014; 12:252â€&quot;62.24590244 12.PeltolaVT, MurtiKG, McCullersJAInfluenza virus neuraminidase contributes to secondary" exact="bacterial pneumonia." post="J Infect Dis2005; 192:249â€&quot;57.15962219 13.ShakhnovichEA, KingSJ, WeiserJNNeuraminidase expressed by"/>
  <result pre="14.Nita-LazarM, BanerjeeA, FengC, et al.Desialylation of airway epithelial cells during" exact="influenza" post="virus infection enhances pneumococcal adhesion via galectin binding. Mol"/>
  <result pre="WyllieAL, et al.Dysbiosis of upper respiratory tract microbiota in elderly" exact="pneumonia" post="patients. ISME J2016; 10:97â€&quot;108.26151645 23.ZhaoJ, SchlossPD, KalikinLM, et al.Decade-long"/>
  <result pre="10:97â€&quot;108.26151645 23.ZhaoJ, SchlossPD, KalikinLM, et al.Decade-long bacterial community dynamics in" exact="cystic fibrosis" post="airways. Proc Natl Acad Sci USA2012; 109:5809â€&quot;14.22451929 24.HuangYJ, SethiS,"/>
  <result pre="SethiS, MurphyT, NariyaS, BousheyHA, LynchSVAirway microbiome dynamics in exacerbations of" exact="chronic obstructive pulmonary disease." post="J Clin Microbiol2014; 52:2813â€&quot;23.24850358 25.YiH, YongD, LeeK, ChoYJ, ChunJProfiling"/>
 </snippets>
</snippetsTree>
